Form 4 Tracker
RHYTHM PHARMACEUTICALS, INC.
RYTM

38 insider filings · Latest: Aug 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 4, 2026Feb 6 11:38 PMHunter C SmithChief Financial Officer
Sale
3,247$105.99$344.1K128,918(D)

View →

Feb 5, 2026Feb 5 9:30 PMHUNTER SMITH
Proposed Sale
18,406$107.97$2.0M

View →

Feb 4, 2026Feb 4 9:21 PMHUNTER SMITH
Proposed Sale
3,247$108.29$351.6K

View →

Dec 11, 2025Dec 11 9:25 PMPAMELA CRAMER
Proposed Sale
3,350$104.77$351.0K

View →

Nov 20, 2025Nov 20 9:23 PMPAMELA CRAMER
Proposed Sale
3,350$103.15$345.6K

View →

Nov 10, 2025Nov 10 9:31 PMPAMELA CRAMER
Proposed Sale
3,515$100.30$352.6K

View →

Nov 7, 2025Nov 7 9:38 PMPAMELA CRAMER
Proposed Sale
19,351$98.49$1.9M

View →

Oct 30, 2025Oct 30 8:16 PMJOSEPH SHULMAN
Proposed Sale
9,748$113.89$1.1M

View →

Oct 28, 2025Oct 28 8:17 PMJOSEPH SHULMAN
Proposed Sale
2,815$111.55$314.0K

View →

Oct 16, 2025Oct 16 8:20 PMJOSEPH SHULMAN
Proposed Sale
14,437$109.35$1.6M

View →

Sep 2, 2025Sep 2 8:41 PMJOSEPH SHULMAN
Proposed Sale
16,781$103.15$1.7M

View →

Aug 21, 2025Aug 21 8:45 PMJOSEPH SHULMAN
Proposed Sale
4,188$98.70$413.4K

View →

Aug 12, 2025Aug 12 8:28 PMHUNTER SMITH
Proposed Sale
28,088$94.31$2.6M

View →

Aug 12, 2025Aug 12 8:26 PMCHRISTOPHER PAUL GERMAN
Proposed Sale
1,500$94.31$141.5K

View →

Aug 11, 2025Aug 11 8:22 PMJOSEPH SHULMAN
Proposed Sale
3,984$91.98$366.4K

View →

Jul 9, 2025Jul 9 8:17 PMCHRISTOPHER PAUL GERMAN
Proposed Sale
3,817$65.14$248.6K

View →

Jul 9, 2025Jul 9 8:17 PMPAMELA CRAMER
Proposed Sale
15,572$65.14$1.0M

View →

Jul 9, 2025Jul 9 8:16 PMHUNTER SMITH
Proposed Sale
42,120$65.14$2.7M

View →

Jul 9, 2025Jul 9 8:16 PMJOSEPH J SHULMAN
Proposed Sale
7,969$65.14$519.1K

View →

Jun 10, 2025Jun 10 8:21 PMCHRISTOPHER PAUL GERMAN
Proposed Sale
2,069$66.72$138.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 1, 2026Mar 4 12:45 AMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
1,1621,162(D)

View →

Mar 2, 2026Mar 3 1:56 AMHunter C SmithChief Financial Officer
Option Exercise
6,099$6.8091,401(D)

View →

Feb 14, 2026Feb 18 9:30 PMYann MazabraudEVP, Head of International
Option Exercise
10,00030,000(D)

View →

Feb 11, 2026Feb 13 10:53 PMJoseph ShulmanChief Technical Officer
Grant/Award
37,500$98.4722,500(D)

View →

Feb 11, 2026Feb 13 10:52 PMDavid P MeekerDirector, President and CEO
Grant/Award
179,750$98.47107,850(D)

View →

Feb 11, 2026Feb 13 10:50 PMYann MazabraudEVP, Head of International
Grant/Award
23,35023,350(D)

View →

Feb 11, 2026Feb 13 10:49 PMJennifer Kayden LeeEVP, Head of North America
Grant/Award
54,150$98.4732,500(D)

View →

Feb 11, 2026Feb 13 10:48 PMChristopher Paul GermanCorporate Controller & CAO
Grant/Award
5,2155,215(D)

View →

Feb 11, 2026Feb 13 10:47 PMAlastair GarfieldChief Scientific Officer
Grant/Award
41,650$98.4725,000(D)

View →

Feb 11, 2026Feb 13 10:45 PMPamela J. CramerChief Human Resources Officer
Grant/Award
29,150$98.4717,500(D)

View →

Feb 11, 2026Feb 13 1:56 AMHunter C SmithChief Financial Officer
Grant/Award
62,500$98.4737,500(D)

View →

Feb 1, 2026Feb 3 9:38 PMYann MazabraudEVP, Head of International
Option Exercise
5,50011,000(D)

View →

Feb 1, 2026Feb 3 9:36 PMHunter C SmithChief Financial Officer
Option Exercise
26,00031,237(D)

View →

Feb 1, 2026Feb 3 9:35 PMJoseph ShulmanChief Technical Officer
Option Exercise
16,96818,750(D)

View →

Feb 1, 2026Feb 3 9:34 PMDavid P MeekerDirector, President and CEO
Option Exercise
68,713100,012(D)

View →

Feb 1, 2026Feb 3 9:33 PMJennifer Kayden LeeEVP, Head of North America
Option Exercise
22,61227,487(D)

View →

Feb 1, 2026Feb 3 9:32 PMChristopher Paul GermanCorporate Controller & CAO
Option Exercise
3,6135,418(D)

View →

Feb 1, 2026Feb 3 9:31 PMAlastair GarfieldChief Scientific Officer
Option Exercise
6,66319,987(D)

View →

Feb 1, 2026Feb 3 9:30 PMPamela J. CramerChief Human Resources Officer
Option Exercise
13,29315,000(D)

View →

← Previous

Page 2 of 2